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Clutathiosz S-transferase P-form @ST-P, EC 2.5.f.18) mRNA was expressed by epidermal growth factor as weif as by _7,4,5,3’tl’-penta~hlor~nated 
biphenyl (PenCB) in primary cultured rat liver paren~h~~a~ cefls. The expression of GST-P was suppressed by jnh~bjtors of protein kinase C and 
dexamethasone, an antagonist of AP-I transcription factor activity, whereas expression of cytochrome P450IA2 by PenCB was not affected by 
these reagents. The AP-1 related transcription factor may be essential for the expression of GST-P by PenCB as also may be a protein kinase C 
type enzyme. 
Gtutathione S-transferase P-form; Coplanar po~y~hlo~nated biphenyl; Epidermaf growth factor; Liver parenchymal cell; Protein kinase C; AP-f 
1. INTRODUCTION 
Polychlo~nated biphenyl (PCS) congeners and re- 
lated compounds are recognized as potent hepa- 
tocarcinogens as a result of experimental and epidemio- 
logical studies [l-4]. These congeners are also terato- 
genie [S] and produce various other adverse effects, such 
as skin lesions. Coplanar PCB congeners, which are 
chlorinated at the meta and pura positions, have more 
severe ef&ects than their non-coplanar counterparts, 
which are substituted at the ortho positions [6]. Copia- 
nar PCB congeners are not significant mutagens and are 
categorized as tumor promoters [2,4]. The mechanism 
by which these adverse effects are induced by coplanar 
PCB congeners is not yet understood, 
Our previous study has shown that glutath~one S- 
transferase P-form (a placental farm, GST-P, EC 
2.5.1.18) was specifically induced in primary cultured 
rat liver parenchymal cells exposed to 3,4,5,3’,4’-penta- 
chlorobiphenyl (PenCB), which is a most toxic coplanar 
congener [7l. GST-P is normally latent in the liver, but 
is expressed in pre~eoplastic hepatic foci and hepa- 
tocarcinomas [8-l 11. 
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Abbreviations: EGF, epidermal growth factor; GAPDH, glyceralde- 
hyde-3-phosphate dehydrogenase; GST-P, glutathione S-transferase 
P-form (EC 2.5.1.18); PCB, polychlorinated biphenyl; PenCB, 
3,4,5,3’,4’-penta-chlorinated biphenyl; TGF-&, transforming growth 
factor-a; TPA, lZ-~tet~d~anoyiphorboi-l3-a~tate; TRE, TPA re- 
sponsive element; XRE, xeno#iotic responsive lement. 
Epidermal growth factor (EGF) is known to induce 
GST-P in rat liver parenchymal cells [12]. EGF exerts 
its effects by activating tyrosine kinase on the EGF 
receptor which in turn activates protein kinases. includ- 
ing protein kinase C 1131, through a cascade system 
[14,15]. Intensive studies revealed that EGF, as well as 
12-O-tetradecanoylphorbol-13-acetate (TPA, an activa- 
tor of protein kinase C), activates the transcription fac- 
tor AP-I (the heterodimer of the proto-oncogene prod- 
uct c&n and c-Fos) and a related tra~~ription factor 
(e.g. the homodimer of c-&n) via protein kinase C 
[15,16]. AP-1 binds to the TPA responsive element 
(TRE) on the flanking sequence of the structural gene 
resulting in its expression [15]. The region 5’-upstream 
of the GST-P gene was shown to contain TRE and 
related enhancer elements termed GPE I and II 11 T-201, 
suggesting that coplanar PCB congeners may mimic the 
effect of EGF, i.e. stimulation of AP-1 activity and 
expression of the GST-P gene. 
We report here that inhibitors of protein kinase C and 
dexamethasone (an antagonist against AP-1 activity) 
suppressed expression of GST-P mRNA caused by 
PenCB, suggesting that an AP-1 related transcription 
factor may play a role in the induction of GST-P by 
coplanar PCB congeners in primary cultured rat liver 
parenchymal cells. 
2. MATERfALS AND METHODS 
2.1. Matertals 
PenCB and pGP5 were kindly provided by Dr. M. Morita and Drs. 
M. Muramatsu and M. Imagawa, respectively. pmP1450 (ATCC# 
63006) was obtained from the American Tissue Culture Collection. 
Mouse EGF were purchased from Wako Pure Chemicals (Tokyo, 
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Japan); rat tmnsfo~ing growth factor-o (TGF-a; s~thetic, residues 
l-50), from Peninsula Laboratories (Belmont, USA); a cDNA probe 
of @actin, from Gncor Inc. (Gaithersburg, USA); genistein and phlo- 
retin, from Extras~~t~esis (Genay, France); H-7, from Seikagaku 
Corp. (Tokyo, Japan); TPA, from LC Service (Woburin, USA) and 
dexamethasone, from Sigma (St. Louis, USA). 
Preparation of cultured cells and their chemicai exposure were es- 
sentially performed as previously reported [A. Liver pamn~h~al cells 
were isolated from a rat liver digested with a collagenase solution, and 
0.85 x lo6 cells were plated in collagen-coated 6-well (diameter 35 mm) 
plates with 1.5 ml of culture medium (William’s E medium (Sigma) 
confining 10 mM sodium pyruvate, 100 U/ml ~ni~llin, 100 @ml 
streptomycin, 0.25 &ml fungizon and 25 mM HEPES/NaOH buffer, 
pH 7.4) containing 1 nM insulin, 100 nM dexamethasone and 10% 
(v/v) fetal calf serum, and were cultured for 4 h in a humidi~ed 
incubator at 37*C under 95% air/5% CO,. The next medium used was 
serum-free culture medium containing 1 nM insulin, 100 nM dexam- 
ethasone and 0.1 #g/ml aprotinin. Following further incubation for 18 
h, the cells were treated with either PenCB or EGF for 12 h or for the 
time indicated with a change in culture medium to one containing 6 
mM nicotinamide, 0.1 &ml aprotinin as well as the other reagents 
at the indicated con~nt~tions. The chemicals and EGF were dis- 
solved in dimethyl sulfoxide and 1% bovine serum alb~in, respec- 
tively, to make stock solutions at l,OOO-fold concentrations and these 
were added to the culture medium immediately before use. 
2.3, Extraction of RNA and northern blot arxdysis of mlWA 
Total RNA was extracted from the cells as described by 
Chomcznski and Sacchi 1211. RNA (20 &r) was separated by electro- 
phoresis on a fo~aldehyde~l.Z% agarose gel. The separated RNA 
was transferred to a nitrocellulose membrane (Schleicher and Schuell, 
Keene, USA) or a nylon membrane (Amersham, fluckinghamshire, 
UK) and immobil~ed [Z&23]. The membranes were hybridized with 
c-DNA probes of GST-P [24] and cytochrome P45OIA2 1251, which are 
an EcoRI-Safi fragment of pGP5 [26] and a PstI fragment of 
pmP1450 1271, respectively, after labeling with [32P]dcTP (Amersham) 
using a random primed DNA labefing kit unhinger, Mannheim, 
Germany). cDNA probes of @-actin and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were used as controls [22]. A cDNA probe 
of GAPDH (the 855 bp fragment corresponding to exons sandwitch~ 
with a portion of the third exon and the ninth exon [ZS]) was kindly 
,C P E, ,C I’ EA 
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Fig. 1. Expression of GST-P mRNA by PenCB and EGF, Primary 
cultured rat liver parencbymal cells were incubated without pretreat- 
ment (C} or in the presence of 100 nM PenCB (P) or 10 ng/ml EGF 
(E) for 6 h and 12 h. After total RNA was extracted from the cells, 
GST-P mRNA levels were determined by Northern blotting analysis. 
28s and 185 indicate the positions of 28s and ItIS RNA, respectively. 
provided by Drs. T. Fujii and Y. Mitsui. The hyb~d~d cDNA was 
detected by autoradiography. 
3. RESULTS 
Primary cultured rat liver pare~ch~~ cells were in- 
cubated with either 100 nM PenCB or 10 nglm’t EGF, 
and the amount of GST-P mRNA was determined. 
PenCB and EGF were both effective inducers of GST-P, 
and comparable amounts of GST-P mRNA were ex- 
pressed after treatment with EGF or PenCB for 12 h 
(Fig. 1). TGF-ol, which shares the same receptor with 
EGF on the plasma membrane, also induced GST-P 
(data not shown). 
PenCB appeared to act on the EGF receptor. To 
verify this, the cells were exposed to PenCB in the pres- 
ence of genistein (a tyrosine kinase inhibitor) [29]. As 
shown in Fig. 2a, genistein had no inhibitor effect on 
GST-P cg mk* 
Actin 
C PO Pl P2 EO El E2 
(b) 
GST-P ai il, 
C PO Pd P2 P3 EO Et E2 E3 
GST-P aF JI 
C PO Pt P2 ECI Et E2 
(d) 
GST-P dllko*F 
GAPDH -mrl)llE 
c PO Pl P2 
Fig. 2, Effect of protein kinase inhibitors on levels of GST-P and other 
mRNAs. Cells were incubate with 100 nM PenCB (lanes PO-P3) or 
10 r&ml EGF (E(rE3) for 12 h in the absence (PO and EO) or presence 
of protein kinase inhibitors (Pl-P3 and El-E3). (a) The level of GST- 
P mRNA was determined after treatment with EGF and PenCB in the 
presence of genistein (Pl and El, 4pM; P2 and E2,20 FM). The level 
of fl-actin mRNA was also determined (Actin). (b) H-7 (Pl and El, 
5 PM; PZ and E2,25 frM; P3 and E3,lOOpM). (c) phloretia (Pl and 
El, 20 puM; P2 and E2, lOO@I). (d) Effect of H-7 on fevels of GST-P, 
cytochrome P45OIA2 (P450) and GAPDH mRNA (Pl and El, 5 PM; 
PZ-and E&25 FM). C indicates mRNA levels in the control cells. 
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expression of GST-P mRNA stimulated by PenCB, al- 
though the expression by EGF was reduced. The 
amount of fl-actin mRNA was basically similar for all 
RNA preparations. This suggests that the tyrosine ki- 
nase activity of the EGF receptor is not directly related 
to the expression of the GST-P gene by PenCB. 
Various protein kinases, including protein kinase C, 
are known to be activated by tyrosine kinase on the 
EGF receptor through the cascade system [16]. One of 
these protein kinases may participate in GST-P expres- 
sion by PenCB. Liver parenchymal cells were treated 
with protein kinase inhibitors in the presence of either 
PenCB or EGF. H-7 (a synthetic inhibitor of protein 
kinase C and cyclic nucleotide dependent protein ki- 
nase) [30] reduced expression of GST-P mRNA by both 
EGF and PenCB to that of the control level (25 PM), 
which is close to the inhibition constant of H-7 for 
protein kinase C activity (6 PM) (Fig. 2b). GST-P ex- 
pression by PenCB was also inhibited by treatment with 
phloretin, an inhibitor of protein kinase C [3 1 J (Fig. 2~). 
Cytochromes P450IAl and P450IA2 are typical gene 
products specifically expressed by coplanar PCB conge- 
ners and related compounds [5] and cytochrome 
P450IA2 is a major iso-protein induced in primary cul- 
tured rat liver parenchymal cells [26,32]. We examined 
whether expression of cytochrome P450IA2, as well as 
GST-P, by PenCB was sensitive to H-7. As shown in 
Fig. 2d, the expression of cytochrome P450IA2 mRNA 
was not inhibited by H-7 at the concentration at which 
GST-P expression was suppressed. Levels of GAPDH 
mRNA were similar among RNA preparations. Expres- 
sion of cytochrome P450IA2 was shown to be unaf- 
fected by H-7. 
Fig. 3 shows that GST-P mRNA was detected after 
the liver parenchymal cells were incubated with 10 ngl 
ml TPA instead of PenCB, however, the level of GST-P 
mRNA induced by TPA was less than that in the PenCB 
treated cells. Expression of GST-P mRNA by TPA was 
also inhibited by H-7 at the same concentration at 
which GST-P expression by PenCB was inhibited (data 
not shown). Dibutyryl cyclic AMP (2 mM), an activator 
of protein kinase A, did not affect expression of GST-P 
mRNA. These results suggest hat protein kinase C or 
a related protein kinase plays a role in the induction of 
GST-P in liver parenchymal cells. 
Cl 23 
Fig. 3. Effect of protein kinase activators on levels of GST-P mRNA. 
After the cells were treated with 100 nM PenCB (lane l), 10 ng/ml TPA 
(lane 2) or 2 mM dibutyryl cyclic AMP (lane 3) for 12 h, the GST-P 
mRNA level was determined. C is the level of GST-P mRNA in the 
control cells. 
GST-P 
P450 
Cl23 
Fig. 4. Suppression of GST-P mRNA by dexamethasone. After the 
cells were exposed to 100 nM PenCB in the absence (lane 1) or pres- 
ence of dexamethasone (lane 2,10 nM; lane 3,100 nM) for 12 h, levels 
of GST-P and cytochrome P450IA2 (P450) mRNA were determined. 
C is the mRNA level in the control cells. 
TRE-containing genes are activated by the binding of 
AP-1 to TRE, and the binding ability of AP-1 is regu- 
lated by protein kinase C through the protein kinase 
cascade system [16]. If AP-1 is required for the induc- 
tion of GST-P by PenCB, this induction could be sup- 
pressed by dexamethasone which acts as an antagonist 
against AP-1 activity by means of a mechanism by 
which the dexamethasone-glucocorticoid receptor com- 
plex is bound to AP-1, abolishing its capacity to bind 
to TRE [35-371. Dexamethasone has been previously 
reported to reduce spontaneous induction of GST-P in 
extended cultures of hepatocytes [38]. As expected, after 
the cells were exposed to PenCB in the presence of 100 
nM dexamethasone, the expression of GST-P mRNA 
was completely suppressed, dropping to the level of 
non-exposed cells (Fig. 4). The expression of cyto- 
chrome P450IA2 mRNA, however, was not affected by 
dexamethasone. 
4. DISCUSSION 
GST-P was shown to be induced by EGF as well as 
by PenCB. Although GST-P expression by PenCB was 
not affected by a tyrosine kinase inhibitor, expression 
by both PenCB and EGF was inhibited by protein ki- 
nase C inhibitors. The present study also demonstrates 
that expression of GST-P mRNA by PenCB was sup- 
pressed by dexamethasone, an antagonist against AP- 1 
activity. These results suggest hat AP-1 or a related 
transcription factor is essential for expression of GST-P 
by coplanar PCB congeners in primary cultured rat liver 
parenchymal cells, as is a protein kinase C type enzyme. 
Coplanar PCB congeners are well-documented in- 
ducers of cytochromes P450IAl and IA2 and several 
drug metabolizing enzymes [31,34]. Gene expression of 
these enzymes is dependent on an intracellular Ah re- 
ceptor and auxiliary factors (Ah receptor system) and 
on 5’-flanking regions of these genes which contain an 
Ah receptor binding site termed the xenobiotic respon- 
sive element (XRE) [34]. Although XRE is not found on 
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the 5’-flanking sequence of GST-P, TRE and related 
responsive lements (GPE I and II) are contained in this 
sequence, and these responsive elements are known to 
be essential for the expression of GST-P in carcinoma 
cells [19,20]. In this study, expression of cytochrome 
P450IA2 gene (a typical XRE containing gene) by 
PenCB was not affected by kinase C inhibitors or by 
dexamethasone, although expression of GST-P was 
suppressed by these reagents, suggesting that the induc- 
tion of GST-P by coplanar PCB congeners is likely to 
be controlled by a novel type of regulatory system other 
than the Ah receptor system [39]. 
The current consensus of how TRE-containing genes 
are expressed is that TPA activates protein kinase C and 
this enzyme regulates activity of AP-1 causing it to bind 
to TRE via phosphorylation through the protein kinase 
cascade [15,40]. Expression of GST-P mRNA by TPA 
in primary cultured liver parenchymal cells indicates 
that TPA activates AP-1 or related transcription factors 
in this type of cell. Dexamethasone suppressed the ex- 
pression of GST-P, suggesting that AP-1 or a related 
transcription factor plays a role in GST-P expression by 
coplanar PCB congeners. C-Jun mRNA was reported 
to be endogenously expressed in primary cultured liver 
parenchymal cells, but there was only a slight expres- 
sion of c-Fos mRNA [24]. We observed that expression 
of these mRNAs was not affected by PenCB (data not 
shown). A homodimer of c-Jun may act as an AP-1 
transcription factor in the cells. 
If AP-1 activity is essential for the expression of GST- 
P by PenCB in these cells, coplanar PCB congeners, as 
well as TPA, may activate protein kinase C or a related 
protein kinase, resulting in activation of AP-1. Copla- 
nar PCB congener-dependent protein kinase activity 
has not been identified, but several observations regard- 
ing this activity have been reported [41,42]. Several fac- 
tors other than a protein kinase might influence gene 
expression of GST-P by coplanar PCB congeners, since 
the magnitude of expression by PenCB was much higher 
than by TPA. Further studies on GST-P expression by 
PenCB in primary cultured liver parenchymal cells are 
important for understanding the various effects of co- 
planar PCB congeners. 
Acknowledgemenu: We wish to thank Dr. M. Morita (NIES), Drs. M. 
Muramatsu (Saitama Medical College), M. Imagawa (Osaka Univ.) 
and Drs. T. Fujii and Y. Mitsui (National Institute of Bioscience and 
Human Technology) for kindly donating PenCB, pGPS and a cDNA 
probe of GAPDH, respectively. We also are grateful to Drs. I. 
Hatayama nd K. Satoh (Hirosaki Univ.) for their critical discussions 
and Drs. T. Suzuki and T. Miura (NIES) for their encouragement. 
REFERENCES 
[1] IARC Monographs on the Evaluation of the Carcinogenic Risk 
of Chemicals to Humans, Vol. 18 (1978) IARCIWHO, Lyon. 
[2] Pitot, H.C., Goldsworthy, T., Cambell, H.A. and Poland, A. 
(1980) Cancer Res. 40, 36163620. 
[3] Kuratsune, M., Nakamura, Y., Ikeda, M. and Hirihata, T. (1987) 
Chemosphere 16, 208552088. 
[4] Bimbaum, L.S. (1991) in: Biological Basis for Risk Assessment 
of Dioxins and Related Compounds (Gallo, M.A., Scheuplein, 
R.J. and van der Heijden, K.A., Eds.) Banbury Report Vol. 35, 
pp. 5147, Cold Spring Harbor Laboratory Press, New York. 
[5] Markes, T.A., Kimmel, G.L. and Staples, R.E. (1981) Toxicol. 
Appl. Pharmacol. 61, 269-276. 
[6] Parkinson, A., Safe, S.H., Robertson, L.W., Thomas, P.E., Ryan, 
D.E., Reik, L.M. and Levin, W. (1983) J. Biol. Chem. 258,5967- 
5976. 
[I Aoki, Y., Satoh, K., Sato, K. and Suzuki, K.T. (1992) Biochem. 
J. 281, 539-543. 
[8] Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Tatematsu, M. 
and Ito, N. (1984) Jpn. J. Cancer Res. 75, 199-202. 
[9] Satoh, K., Kitahara, A., Soma, Y., Inaba, Y., Hatayama, I. and 
Sato, K. (1985) Proc. Natl. Acad. Sci. USA 82, 39643968. 
[lo] Sugioka, Y., Fujii-Kuriyama, Y., Kitagawa, T. and Muramatsu, 
M. (1985) Cancer Res. 45, 365-378. 
[11] Sato, K. (1989) Adv. Cancer Res. 52, 205-255. 
[12] Hatayama, I., Yamada, Y., Tanaka, K., Ichihara, A. and Sato, 
K. (1991) Jpn. J. Cancer Res. 82, 807-814. 
[13] Nishizuka, Y. (1986) Science 233, 305-312. 
[14] Yarden, Y. and Ulhich, A. (1988) Annu. Rev. Biochem. 57, 
443478. 
1151 
U61 
[I71 
U81 
[I91 
PO1 
WI 
t221 
~231 
v41 
~251 
WI 
v71 
WI 
t291 
t301 
[311 
~321 
[331 
[341 
[351 
[361 
Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B. Gra- 
ziani, A., Kapeller, R. and Soltoff, S. (1991) Cell 64, 281-302. 
Quantin, B. and Breathnach, R. (1988) Nature 334, 5388539. 
Sakai, M., Okuda, A. and Muramatsu, M. (1988) Proc. Natl. 
Acad. Sci. USA 85, 94969460. 
Okuda, A., Imagawa, M., Maeda, Y., Sakai, M. and Muramatsu, 
M. (1989) J. Biol. Chem. 264, 16919-16926. 
Okuda, A., Imagawa, M., Sakai, M. and Muramatsu, M. (1990) 
EMBO J. 9, 1131-1135. 
Sakai, M., Muramatsu, M. and Nishi, S. (1992) Biochem. Bio- 
phys. Res. Commun. 187, 976-983. 
Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162,156 
159. 
Saida, K., Mitsui, Y. and Ishida, N. (1989) J. Biol. Chem. 264, 
14613-14616. 
Kunimoto, M., Otto, E. and Bennett, V. (1991) J. Cell Biol. 115, 
1319-1331. 
Morimura, S., Okuda, A., Sakai, M., Imagawa, M. and Mu- 
ramatsu, M. (1992) Cell Growth Differ. 3, 685691. 
Silver, G. and Krauter, K.S. (1988) J. Biol. Chem. 263, 11802- 
11807. 
Suguoka, Y., Kano, T., Okuda, A., Sakai, M., Kitagawa, T. and 
Muramatsu, M. (1985) Nucleic Acids Res. 13, 60496057. 
Kimura, S., Gonzalez, F.J. and Nebert, D.W. (1984) J. Biol. 
Chem. 259, 10705-10703. 
Tso, J.Y., Sun, X.H., Kao, T., Reece, K.S. and Wu, R. (1985) 
Nucleic Acid. Res. 13, 2485-2502. 
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, 
S., Itoh, N., Shibuya, M. and Fukami, Y. (1987) J. Biol. Chem. 
262, 5592-5595. 
Hidaka, H., Inagaki, M., Kawamoto, S. and Sasaki, Y. (1984) 
Biochemistry 23, 50365041. 
Gschwendt, M., Horn, F., Kittstein, W., Furstenberger, G., Be- 
semfelder, E. and Marks, F. (1984) Biochem. Biophys. Res. Com- 
mun. 124, 63-68. 
Aoki, Y., Silbergeld, E.K., Max, S.R. and Fowler, B.A. (1991) 
Biochem. Pharmacol. 42, 1195-1201. 
Nebert, D.W, and Gonzalez, F.J. (1987) Annu. Rev. Biochem. 56, 
945-993. 
Yao, E.F. and Denison, M.S. (1992) Biochemistry 31,506&5067. 
Jonat, C., Rahmsdorf, H.J., Park, K., Cato, A.C.B., Gebel, S., 
Ponta, H.and Herrlich, P. (1990) Cell 62, 1189-1204. 
Yang-Yen, H., Chambard, J., Sun, Y., Smeal, T., Schmidt, T.J., 
Drouin, J. and Karin, M. (1990) Cell 62, 120551215. 
117 
Volume 333, number I,2 FEBS LETTERS October 1993 
[37] Schule, R., Rangarajau, P., Kliewer, S., Ransone, L.J., Bolado, 
J., Yang, N., Verma, I.M. and Evans, R.M. (1990) Cell 62,1217- 
1226. 
[38J Abramovitz, M., Ishigaki, S. and Listowsky, I. (1989) Hepatol- 
ogy 9,235239. 
[39] Pickett, C.B. and Lu, A.Y.H. (1989) Annu. Rev. Biochem. 58, 
743-764. 
[40] Boyle, W.J., Smeal, T., Defize, L.H.K., Angel, P., Woodgett, 
JR., Karin, M. and Hunter, T. (1991) Cell 64, 573-584. 
[41] Bombick, D.W., Jankun, J., Tultis, K. and Matsumura, F. (1988) 
Proc. Nat]. Acad. Sci. USA 85,41284132. 
[42] Moser, G.J. and Smart, R.C. (1989) Car&genesis IO, 851-856. 
118 
